Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Planning and Procedures; Notice of Meeting, 28964-28965 [E5-2510]

Download as PDF 28964 Federal Register / Vol. 70, No. 96 / Thursday, May 19, 2005 / Notices NUCLEAR REGULATORY COMMISSION [Docket No. 030–02489] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for Princeton Healthcare System’s Facility in Princeton, NJ Nuclear Regulatory Commission. ACTION: Notice of availability. AGENCY: FOR FURTHER INFORMATION CONTACT: Sandra Gabriel, Medical Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale Road, King of Prussia, Pennsylvania 19406, telephone (610) 337–5182, fax (610) 337–5269; or by e-mail: slg2@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The Nuclear Regulatory Commission (NRC) is issuing a license amendment to Princeton HealthCare System for Materials License No. 29–06750–01, to authorize release of its facility at Princeton House Behavioral Health, 905 Herrontown Road in Princeton, New Jersey for unrestricted use. NRC has prepared an Environmental Assessment (EA) in support of this action in accordance with the requirements of 10 CFR Part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be issued following the publication of this Notice. II. EA Summary The purpose of the action is to authorize the release of the licensee’s facility at Princeton House Behavioral Health, 905 Herrontown Road in Princeton, New Jersey, for unrestricted use. Princeton HealthCare System was authorized by NRC from July 21, 1993, to use radioactive materials at this site for research and development involving absorption, dilution, metabolism, and excretion studies in humans, in association with Bristol Myers Squibb. In 1998, Princeton HealthCare System ceased operations with licensed materials at the Princeton House Behavioral Health site, and in 2004 requested that NRC release the facility for unrestricted use. Princeton HealthCare System has conducted surveys of the facility and determined that the facility meets the license termination criteria in Subpart E of 10 CFR Part 20. The NRC staff has prepared an EA in support of the license amendment. The VerDate jul<14>2003 22:14 May 18, 2005 Jkt 205001 facility was remediated and surveyed prior to the licensee requesting the license amendment. The NRC staff has reviewed the information and final status survey submitted by Princeton HealthCare System. Based on its review, the staff has determined that there are no additional remediation activities necessary to complete the proposed action. Therefore, the staff considered the impact of the residual radioactivity at the facility and concluded that since the residual radioactivity meets the requirements in Subpart E of 10 CFR Part 20, a Finding of No Significant Impact is appropriate. III. Finding of No Significant Impact The staff has prepared the EA (summarized above) in support of the license amendment to release the facility at Princeton House Behavioral Health, 905 Herrontown Road Way in Princeton, New Jersey, for unrestricted use. The NRC staff has evaluated Princeton HealthCare System’s request and the results of the surveys and has concluded that the completed action complies with the criteria in Subpart E of 10 CFR Part 20. On the basis of the EA, the NRC has concluded that the environmental impacts from the action are expected to be insignificant and has determined not to prepare an environmental impact statement for the action. IV. Further Information Documents related to this action, including the application for the license amendment and supporting documentation, are available electronically at the NRC’s Electronic Reading Room at https://www.nrc.gov/ reading-rm/adams.html. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC’s public documents. The ADAMS accession numbers for the documents related to this Notice are: Environmental Assessment (ML050900333), letter dated November 24, 2004 with attached closeout survey results (ML043410218), and letter dated March 14, 2005 (ML050830030). Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS, should contact the NRC PDR Reference staff by telephone at (800) 397–4209 or (301) 415–4737, or by email to pdr@nrc.gov. These documents may also be examined, and/or copied for a fee, at the NRC PDR, located at One White Flint North, 11555 Rockville Pike (First Floor), Rockville, MD 20852. The PDR is open from 7:45 a.m. to 4:15 p.m., PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Monday through Friday, except on Federal Holidays; and at the Region I Office, 475 Allendale Road, King of Prussia, Pennsylvania 19406. Dated at King of Prussia, Pennsylvania this 10th day of May, 2005. For the Nuclear Regulatory Commission. Pamela J. Henderson, Chief, Medical Branch, Division of Nuclear Materials Safety, Region I. [FR Doc. E5–2509 Filed 5–18–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Planning and Procedures; Notice of Meeting The ACRS Subcommittee on Planning and Procedures will hold a meeting on May 31, 2005, Room T–2B1, 11545 Rockville Pike, Rockville, Maryland. The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to 5 U.S.C. 552b(c)(2) and (6) to discuss organizational and personnel matters that relate solely to the internal personnel rules and practices of the ACRS, and information the release of which would constitute a clearly unwarranted invasion of personal privacy. The agenda for the subject meeting shall be as follows: Tuesday, May 31, 2005—10 a.m.–11:30 a.m. The Subcommittee will discuss proposed ACRS activities and related matters. The Subcommittee will gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official, Mr. Sam Duraiswamy (telephone: 301–415–7364) between 7:30 a.m. and 4:15 p.m. (ET) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Electronic recordings will be permitted only during those portions of the meeting that are open to the public. Further information regarding this meeting can be obtained by contacting the Designated Federal Official between 7:30 a.m. and 4:15 p.m. (ET). Persons planning to attend this meeting are urged to contact the above named individual at least two working days prior to the meeting to be advised of any potential changes in the agenda. E:\FR\FM\19MYN1.SGM 19MYN1 Federal Register / Vol. 70, No. 96 / Thursday, May 19, 2005 / Notices Dated: May 11, 2005. Michael R. Snodderly, Acting Branch Chief, ACRS/ACNW. [FR Doc. E5–2510 Filed 5–18–05; 8:45 am] SECURITIES AND EXCHANGE COMMISSION BILLING CODE 7590–01–P RIN 3235–AJ17 Mutual Fund Redemption Fees NUCLEAR REGULATORY COMMISSION Securities and Exchange Commission. ACTION: Notice of OMB Approval of Collections of Information. AGENCY: Advisory Committee on Reactor Safeguards Meeting of the Subcommittee on Plant License Renewal; Notice of Meeting The ACRS Subcommittee on Plant License Renewal will hold a meeting on May 31, 2005, Room T–2B3, 11545 Rockville Pike, Rockville, Maryland. The entire meeting will be open to public attendance. The agenda for the subject meeting shall be as follows: Tuesday, May 31, 2005—12:30 p.m. until 5 p.m. The purpose of this meeting is to discuss the License Renewal Application and associated Safety Evaluation Report (SER) with Open Items related to the License Renewal of the Point Beach Nuclear Plant, Units 1 and 2. The Subcommittee will hear presentations by and hold discussions with representatives of the NRC staff, the Nuclear Management Company, LLC, and other interested persons regarding this matter. The Subcommittee will gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official, Mr. Cayetano Santos (telephone 301–415–7270) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Electronic recordings will be permitted. Further information regarding this meeting can be obtained by contacting the Designated Federal Official between 7:30 a.m. and 4:15 p.m. (ET). Persons planning to attend this meeting are urged to contact the above named individual at least two working days prior to the meeting to be advised of any potential changes to the agenda. Dated: May 11, 2005. Michael R. Snodderly, Acting Branch Chief, ACRS/ACNW. [FR Doc. E5–2511 Filed 5–18–05; 8:45 am] BILLING CODE 7590–01–P VerDate jul<14>2003 22:14 May 18, 2005 [Release Nos. IC–26867; File No. S7–11– 04] Jkt 205001 FOR FURTHER INFORMATION CONTACT: William C. Middlebrooks, Jr., Senior Counsel, Office of Regulatory Policy, Division of Investment Management, (202) 551–6792, at the Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549–0506. SUPPLEMENTARY INFORMATION: The Office of Management and Budget has approved the collection of information requirements described in the release entitled ‘‘Mutual Fund Redemption Fees.’’ 1 This collection is titled ‘‘Rule 22c–2’’ (OMB Control No. 3235–0620). Dated: May 13, 2005. J. Lynn Taylor, Assistant Secretary. [FR Doc. 05–9970 Filed 5–18–05; 8:45 am] BILLING CODE 8010–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In Sino Silver Corp.; Order of Suspension of Trading May 17, 2005. It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension of trading in the securities of Sino Silver Corp. (‘‘Sino’’), trading under the stock symbol SSLV on the Over-the-Counter Bulletin Board (‘‘OTCBB’’). The Commission has concerns about the accuracy and completeness of information about Sino contained in press releases and public filings with the Commission relating to a change in control over Sino. In addition, the Commission is concerned that Sino, its affiliates, and others may be engaged in the unlawful distribution of restricted Sino securities through the OTCBB. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the above listed company is suspended for the period from 9:30 a.m. EST, May 17, 2005 through 11:59 p.m. EST, on May 31, 2005. By the Commission. Jonathan G. Katz, Secretary. [FR Doc. 05–10091 Filed 5–17–05; 11:39 am] BILLING CODE 8010–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–51689; File No. SR–Amex– 2005–039] Self-Regulatory Organizations; American Stock Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Relating to Revisions to the Series 4 Examination Program May 12, 2005. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 notice is hereby given that on April 8, 2005, the American Stock Exchange LLC (‘‘Amex’’ or ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by Amex. Amex has designated the proposed rule change as one constituting a stated policy, practice, or interpretation with respect to the meaning, administration, or enforcement of an existing rule of Amex pursuant to Section 19(b)(3)(A)(i) of the Act 3 and Rule 19b–4(f)(1) thereunder,4 which renders the proposal effective upon filing with the Commission. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change Amex is filing revisions to the study outline and selection specifications for the Limited Principal—Registered Options (Series 4) examination (‘‘Series 4 Examination’’). The proposed revisions update the material to reflect changes to the laws, rules, and regulations covered by the Series 4 Examination. 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 15 U.S.C. 78s(b)(3)(A)(i). 4 17 CFR 240.19b–4(f)(1). 2 17 1 Investment Company Act Rel. No. 26782 (Mar. 11, 2005) [70 FR 13328 (Mar. 18, 2005)]. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 28965 E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 70, Number 96 (Thursday, May 19, 2005)]
[Notices]
[Pages 28964-28965]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-2510]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on Reactor Safeguards; Subcommittee Meeting on 
Planning and Procedures; Notice of Meeting

    The ACRS Subcommittee on Planning and Procedures will hold a 
meeting on May 31, 2005, Room T-2B1, 11545 Rockville Pike, Rockville, 
Maryland. The entire meeting will be open to public attendance, with 
the exception of a portion that may be closed pursuant to 5 U.S.C. 
552b(c)(2) and (6) to discuss organizational and personnel matters that 
relate solely to the internal personnel rules and practices of the 
ACRS, and information the release of which would constitute a clearly 
unwarranted invasion of personal privacy.
    The agenda for the subject meeting shall be as follows:

Tuesday, May 31, 2005--10 a.m.-11:30 a.m.

    The Subcommittee will discuss proposed ACRS activities and related 
matters. The Subcommittee will gather information, analyze relevant 
issues and facts, and formulate proposed positions and actions, as 
appropriate, for deliberation by the full Committee.
    Members of the public desiring to provide oral statements and/or 
written comments should notify the Designated Federal Official, Mr. Sam 
Duraiswamy (telephone: 301-415-7364) between 7:30 a.m. and 4:15 p.m. 
(ET) five days prior to the meeting, if possible, so that appropriate 
arrangements can be made. Electronic recordings will be permitted only 
during those portions of the meeting that are open to the public.
    Further information regarding this meeting can be obtained by 
contacting the Designated Federal Official between 7:30 a.m. and 4:15 
p.m. (ET). Persons planning to attend this meeting are urged to contact 
the above named individual at least two working days prior to the 
meeting to be advised of any potential changes in the agenda.


[[Page 28965]]


    Dated: May 11, 2005.
Michael R. Snodderly,
Acting Branch Chief, ACRS/ACNW.
[FR Doc. E5-2510 Filed 5-18-05; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.